PT Siloam International Hospitals (SILO) Fundamentals 2026 — P/E 23.8x, Revenue Analysis | SniperIQ
PT Siloam International Hospitals (SILO) is a ID-listed Healthcare company in Medical - Care Facilities with a market capitalization of Rp27.27T, trading at Rp2100.00 on the JKT. This SniperIQ fundamentals page covers PT Siloam International Hospitals's valuation (P/E 23.8x, P/B 2.7x), profitability (net margin 8.8%), revenue (Rp12.85T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Siloam International Hospitals's market cap?
PT Siloam International Hospitals (SILO) has a market capitalization of approximately Rp27.27T, trading at Rp2100.00 on the JKT. Market cap moves with the live share price.
What is PT Siloam International Hospitals's P/E ratio?
PT Siloam International Hospitals's trailing twelve-month P/E ratio is 23.8x, with a price-to-book (P/B) of 2.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Siloam International Hospitals?
PT Siloam International Hospitals runs a net profit margin of 8.8%, a gross margin of 38.8%, and an operating margin of 13.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Siloam International Hospitals generate?
PT Siloam International Hospitals reported revenue of Rp12.85T for fiscal year 2025, with net income of Rp1.11T and earnings per share (EPS) of 85.68. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Siloam International Hospitals pay a dividend?
PT Siloam International Hospitals does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Siloam International Hospitals financially healthy?
PT Siloam International Hospitals carries a debt-to-equity ratio of 0.21x and a current ratio of 0.71x, with a market beta of -0.06. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Siloam International Hospitals a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Siloam International Hospitals (SILO) the key facts are: market cap Rp27.27T, P/E 23.8x, revenue Rp12.85T, 52-week range 1830-2880. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Siloam International Hospitals's full fundamentals live
Get PT Siloam International Hospitals's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.